New Delhi: India said on Friday it had not received any request from Pakistan for supply of Covid-19 vaccines even as it began commercial exports of doses by sending two million doses each to Brazil and Morocco.

The Ministry of External Affairs (MEA) Spokesperson Anurag Srivastava on January 22 said that he is not aware of any request either G2G or commercial basis by Pakistan for Indian made vaccines. “I am not aware of any request for the supply for Indian made vaccines by Pakistan on a Government to Government or commercial basis,” said MEA Spokesperson.

On Friday, India began commercial exports and sent two million doses each to Brazil and Morocco. India began sending coronavirus vaccines as grant assistance to the neighbouring countries on Wednesday.

The MEA spokesperson said there was interest in many countries in accessing vaccines from India which is the global hub for vaccine production. "Keeping in view the domestic requirements of the phased rollout, India will continue to supply Covid-19 vaccines to partner countries over the coming weeks and months in a phased manner. It will be ensured that domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad," said Srivastava.

India is one of the world's biggest drugmakers, and an increasing number of countries have already approached it for procuring the coronavirus vaccines. India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country.

While Oxford-AstraZeneca's Covishield is being manufactured by the Serum Institute, and Covaxin is being produced by Bharat Biotech. India had earlier supplied hydroxychloroquine, Remdesivir and paracetamol tablets, as well as diagnostic kits, ventilators, masks, gloves and other medical supplies to a large number of countries to help them deal with the pandemic.